New PET tracer could sharpen cancer detection
NCT ID NCT05641896
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a new radioactive tracer called [18F]FAPI-74 for PET scans in people with gastrointestinal cancers, including liver, bile duct, stomach, pancreatic, and colorectal cancers. The goal was to see if the tracer can accurately detect cancer cells by comparing scan results with tissue samples. A total of 109 participants were enrolled, and the study has been completed.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- [18F]FAPI-74 (a radioactive tracer for PET imaging)
- What this could lead to
- If successful, this imaging method could help doctors more accurately detect and locate gastrointestinal cancers, potentially guiding better treatment decisions.
- What could go wrong
- This is a phase 2 study with a moderate number of participants. The imaging agent may not prove more effective than current methods, and results may not apply to all cancer types.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHOLANGIOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
BAMF Health
Grand Rapids, Michigan, 49503, United States
-
Massachusetts general hospital
Boston, Massachusetts, 02114, United States
-
Mayo Clinic Rochester
Rochester, Minnesota, 55902, United States
-
Memorial Sloan Kettering Cancer Center (MSKCC)
New York, New York, 10065, United States
-
Northwell Health
Lake Success, New York, 11042, United States
-
University of California Los Angeles (UCLA) Health
Los Angeles, California, 90095, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can pancreatic Cancer's inflammatory footprint be stopped?
- Could a simple scan and blood test outsmart liver cancer?
- Can a plasma beam stop colon polyps from coming back?
- Can AI-Guided home training boost recovery from gastric cancer surgery?
- A stitch in time: could a device make abdominal closure safer?
- Can we predict chemo brain before it happens?